Patients successfully Self-Inject Muscle-Weakness medication at home
NCT ID NCT06471361
Summary
This study tested whether people with generalized myasthenia gravis (a condition causing muscle weakness) could safely and effectively give themselves their medication using a new auto-injector device at home. Thirty-one adults who were already taking the medication zilucoplan participated. Researchers measured how well participants could use the device to deliver the full dose and monitored for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERALIZED MYASTHENIA GRAVIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dv0013 40605
Poznan, Poland
-
Dv0013 40609
Katowice, Poland
-
Dv0013 40759
Krakow, Poland
-
Dv0013 40760
Oxford, United Kingdom
-
Dv0013 50555
Austin, Texas, 78759, United States
-
Dv0013 50556
Chapel Hill, North Carolina, 27599, United States
-
Dv0013 50628
New Haven, Connecticut, 06511, United States
-
Dv0013 50634
Tampa, Florida, 33612, United States
-
Dv0013 50635
Columbus, Ohio, 43221, United States
-
Dv0013 50636
Greenfield, Wisconsin, 53228, United States
-
Dv0013 50648
Columbia, Missouri, 64212, United States
Conditions
Explore the condition pages connected to this study.